New Caledonia vs Puerto Rico: The number of people with susceptibility test result for rifampicin
New Caledonia
15
in 2021
Puerto Rico
14
in 2021
New Caledonia rank
135th
Puerto Rico rank
136th
The number of people with susceptibility test result for rifampicin over time
- New Caledonia
- Puerto Rico
How they compare
New Caledonia currently reports 15 against 14 in Puerto Rico, a difference of 1.
That makes New Caledonia's figure about 1.1 times Puerto Rico's.
The two have swapped places 3 times across 5 shared years of data; in 2017 it was Puerto Rico ahead.
New Caledonia ranks 135th and Puerto Rico ranks 136th of 155 countries.
Across the 2 decades both report, New Caledonia averaged higher in 1 and Puerto Rico in 1.
Head to head by decade
| Decade | New Caledonia | Puerto Rico | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 21.33 | 25.33 | 4 | Puerto Rico |
| 2020s | 19.5 | 18 | 1.5 | New Caledonia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, New Caledonia or Puerto Rico?
- New Caledonia, at 15 against 14 in Puerto Rico as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between New Caledonia and Puerto Rico?
- 1, with New Caledonia ahead.
- How many years of comparable data are there for New Caledonia and Puerto Rico?
- 5 years are reported by both, from 2017 to 2021.
- How do New Caledonia and Puerto Rico rank globally for the number of people with susceptibility test result for rifampicin?
- New Caledonia ranks 135th and Puerto Rico ranks 136th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.